The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, January 26, 2022
Immunocore Holdings announced the approval from the United States Food and Drug Administration (FDA) of KIMMTRAK® (tebentafusp-tebn) for the treatment...
read more
Thursday, January 27, 2022
Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the adjuvant treatment of adults ...
read more
Thursday, January 27, 2022
This week, FDA published a series of guidances focused on generic drug application submissions, labeling, and review. These guidances are part of our ...
read more
Merck and Ridgeback Biotherapeutics announced data from six preclinical studies demonstrating that molnupiravir, an investigational oral antiviral ...
read more
As part of FDA’s efforts to help ensure Americans have access to compounded medicines when a patient’s medical needs cannot be met by an FDA-approved ...
read more
Regeneron Pharmaceuticals, Inc. and Sanofi announced the voluntary withdrawal of the supplemental Biologics License Application (sBLA) for Libtayo® (...
read more
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ...
read more
Wednesday, February 02, 2022
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (...
read more
Wednesday, February 02, 2022
B. Braun Medical Inc. announced that the company has received final approval by the U.S. Food & Drug Administration (FDA) for its new pharmaceutical ...
read more
Wednesday, February 02, 2022
Takeda Pharmaceutical Company Limited announced that the U.S. Food & Drug Administration (FDA) approved VONVENDI® [von Willebrand factor (Recombinant)...
read more
Tuesday, February 01, 2022
Nordic Pharma announced that on the 24th of January, the European Commission (EC) approved the new indication for Teysuno® (tegafur/gimeracil/oteracil...
read more
Tuesday, February 01, 2022
Pfizer Inc. and Ionis Pharmaceuticals, Inc. announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557),...
read more
Wednesday, February 02, 2022
German independent research institute BioMed X announced the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research ...
read more
Wednesday, February 02, 2022
Eli Lilly and Company and Incyte announced updates on the Phase 3 development program for OLUMIANT® (baricitinib) in adults with active systemic lupus...
read more
Wednesday, February 02, 2022
Pfizer Inc. and BioNTech SE announced that following a request from the U.S. Food and Drug Administration (FDA) the companies have initiated a rolling...
read more